A review on potential of PARP inhibitors in the treatment of prostate cancer

A review on potential of PARP inhibitors in the treatment of prostate cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografiska uppgifter
Huvudupphovsman:	Islam, Saidul
Övriga upphovsmän:	Sharmin, Shahana
Materialtyp:	Lärdomsprov
Språk:	English
Publicerad:	Brac University 2022
Ämnen:	Prostate cancer Therapeutic approaches mCRPC PARP inhibitors Olaparib Cancer > Treatment Enzyme inhibitors > Therapeutic use Cancer > Gene therapy
Länkar:	http://hdl.handle.net/10361/17308

Liknande verk

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
av: Karim, Azrin
Publicerad: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Flora, Sanzida Alam
Publicerad: (2024)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
av: Meem, Manila
Publicerad: (2023)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
av: Alam, Tahera
Publicerad: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
av: Jahan, Nusrat
Publicerad: (2024)

Association of XRCC1 and XPD polymorphism with risk of prostate cancer in Bangladesh population
av: Ahmed, Nafisa
Publicerad: (2023)

Immunotherapy in the Management of Lung Cancer
av: Tasnim, Humayra
Publicerad: (2022)

A review on triple-negative breast cancer and its potential treatment
av: Niasa, Jannatul Ferdous
Publicerad: (2023)

Stem cells as therapeutic carrier in cancer treatment
av: Anika, Mysha Yeasmin
Publicerad: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
av: Hasan, Amit
Publicerad: (2024)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
av: Chakraborty, Anuradha
Publicerad: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
av: Khan, Muidul Hasan
Publicerad: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
av: Roy, Hredita
Publicerad: (2018)

Recent advances in Cancer treatment targeting autophagy and future aspects
av: Emon, Kamrul Hasan
Publicerad: (2022)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
av: Mirza, Maisa Tasnim
Publicerad: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
av: Khan, Rezia Nowrin
Publicerad: (2021)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
av: Nuha, Nabiha Tahsin
Publicerad: (2024)

Role of statins as antagonists of SPARC in gastric cancer
av: Shahmat, Rad
Publicerad: (2019)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
av: Sorno, Rubina Haque
Publicerad: (2024)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
av: Ratu, Tabassum
Publicerad: (2024)

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia
av: Choki, Kinley
Publicerad: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
av: Razna, Amrin Islam
Publicerad: (2019)

A comprehensive review on drug repurposing in cancer treatment
av: Sarkar, Onusree
Publicerad: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
av: Mahaleka, Aarshi
Publicerad: (2024)

Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
av: Shaikat, Mahdi Mubin
Publicerad: (2023)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
av: Hasan, Sakib
Publicerad: (2024)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
av: Nawar, Anika
Publicerad: (2019)

Statistics and informatics in molecular cancer research

Identification of FAP inhibitors using in silico simulation study
av: Deeba, Maliha Tasnim
Publicerad: (2018)

Targeting BRAFV600E in the treatment of CRC
av: Roja, Mashwiyat Samrin
Publicerad: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
av: Alam, Kazi Tasnuva
Publicerad: (2022)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
av: Rahman, Sanjida
Publicerad: (2024)

Biosimilar in lymphoma treatment
av: Tanisha, Mehrin Haque
Publicerad: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
av: Khondokar, Faiza
Publicerad: (2022)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
av: Islam, Nahidul
Publicerad: (2023)

A review on Single Nucleotide Polymorphism (SNPs) and their effect on cancer risk in South Asian population
av: Beruni, Sajid Mahmud Al
Publicerad: (2022)

Oncogenes: new targets in cancer treatment
av: Chowdhury, Waseka Shams
Publicerad: (2020)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
av: Muntaha, Habibatul
Publicerad: (2023)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
av: Haque, Mushfiqul
Publicerad: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
av: Karim, Samia Binte
Publicerad: (2024)